Back
Lyell Immunopharma Vs. Entrada Therapeutics Industry Stock Comparison
Buy
59
LYEL
Lyell Immunopharma
Last Price:
2.74
Seasonality Move:
37.44%
Buy
64
TRDA
Entrada Therapeutics
Last Price:
15.00
Seasonality Move:
71.95%
Buy
59
Lyell Immunopharma (LYEL)
is a Buy
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $2.74. The Score for LYEL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $14.99. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $2.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $14.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight selling pressure.
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 60.07 | Buy |
| Chaikin Money Flow: | -575819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.26 - 2.58) | Buy |
| Bollinger Bands (100): | (1.93 - 2.53) | Buy |
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 66.04 | Buy |
| Chaikin Money Flow: | -26222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.33 - 14.23) | Buy |
| Bollinger Bands (100): | (12.69 - 15.19) | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.59 | Buy |
| 20-day SMA: | 2.44 | Buy |
| 50-day SMA: | 2.32 | Buy |
| 200-day SMA: | 2.06 | Buy |
| 8-day EMA: | 2.61 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 2.37 | Buy |
| 200-day EMA: | 2.36 | Buy |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.43 | Buy |
| 20-day SMA: | 13.51 | Buy |
| 50-day SMA: | 13.23 | Buy |
| 200-day SMA: | 14.43 | Buy |
| 8-day EMA: | 14.41 | Buy |
| 20-day EMA: | 13.82 | Buy |
| 50-day EMA: | 13.55 | Buy |
| 200-day EMA: | 14.11 | Buy |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.49 per share, a decrease this year of $0.34 per share, and a decrease next year of $3.22 per share.
Lyell Immunopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Entrada Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||